<DOC>
	<DOCNO>NCT01096277</DOCNO>
	<brief_summary>Glucagon-like peptide 1 ( GLP-1 ) 30-amino acid gut hormone secrete nutrient-dependent manner stimulates insulin secretion inhibits glucagon secretion gastric emptying , thereby reduce postprandial glycemia.1,2 GLP-1 derive posttranslational proteolysis preproglucagon , peptide sequence identical mouse , rat , human.2,3 After secretion enteroendocrine L cell , GLP-1 ( 7-36 ) amide rapidly degrade dipeptidyl peptidase-4 ( DPP-4 ) N-terminally truncated metabolite GLP-1 ( 9-36 ) , interact know GLP-1 receptor.4,5 The diverse action GLP-1 include proliferation , differentiation , protection apoptosis pancreatic Î² cell induction satiety . GLP-1 also improve memory learning , stimulate afferent sensory nerve , neuroprotective functions.1,6 Furthermore , GLP-1 receptor agonist report cardiac vascular action rodent human include effect contractility , blood pressure , cardiac output,7-10 cardioprotection.11-14</brief_summary>
	<brief_title>Vascular Effects Sitagliptin Diabetes Mellitus</brief_title>
	<detailed_description>The aim study evaluate effect therapy DPP-4-inhibitor sitagliptin prognostic relevant endothelial function endothelial progenitor cell patient type 2 diabetes mellitus . Primary endpoint : Endothelium-dependent vasodilation treatment patient type 2 diabetes mellitus DPP-4-inhibitor Sitagliptin placebo treatment respectively . Secondary endpoint : effect sitagliptin mobilization , NO-production vivo regenerative capacity human endothelial progenitor cell treatment patient type 2 diabetes mellitus DPP-4-inhibitor sitagliptin placebo treatment respectively</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Type 2 Diabetes mellitus Allergy sitagliptin Treatment PPARgamma agonist</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>